A Genetic Model of Constitutively Active Integrin CD11b/CD18.

Area of Science:

• Immunology
• Molecular Biology
• Pharmacology

Background:

• Integrin CD11b/CD18 (αMβ2, Mac-1, CR3) activation has demonstrated anti-inflammatory effects.
• Genetic models offer a direct system for studying CD11b agonism mechanisms.

Purpose of the Study:

• To create and characterize a novel knock-in mouse model with constitutively active CD11b.
• To investigate the role of genetic CD11b activation in inflammatory responses and disease.

Main Methods:

• Generated a knock-in mouse model by genetically targeting the Itgam gene, introducing an I332G point mutation in CD11b.
• Assessed neutrophil adhesion and chemotaxis in vitro.
• Evaluated leukocyte recruitment in vivo using models of sterile peritonitis and atherosclerosis.

Main Results:

• The I332G mutation resulted in a higher-affinity conformation of the CD11b αA-domain.
• In vitro, knock-in neutrophils showed increased fibrinogen adhesion and decreased chemotaxis.
• In vivo, CD11b I332G mice exhibited reduced neutrophil and macrophage recruitment in peritonitis and protected against atherosclerosis.

Conclusions:

• The novel CD11b I332G knock-in mouse model provides a valuable tool for studying integrin activation.
• Constitutive genetic activation of CD11b can modulate leukocyte recruitment and ameliorate inflammatory diseases like atherosclerosis.